S3 Fig demonstrates sensitivity and specificity in the Pittsburgh, New York (NY) and Dundee samples for the same panel of 6 tumour antigens (p53, AFP, K RAS, Annexin, RAF1 and NY-CO16) based upon the same cut-off point (95th percentile of the healthy control group). Here, TP53 is linked to neoplasm.